Drug intelligence / Profile preview

lidocaine hydrochloride + bacitracin zinc + neomycin sulfate + polymyxin b

Development stage
Approved
Lead developer
Johnson & Johnson Consumer Inc. (J&JCI)
Modality
Small Molecules
Administration
Topical
01

Overview

Lidocaine hydrochloride + bacitracin zinc + neomycin sulfate + polymyxin b is an over-the-counter topical combination small-molecule drug product that combines a local anesthetic with three topical antibiotics for first-aid use on minor cuts, scrapes, and burns. Lidocaine hydrochloride provides temporary pain relief by blocking voltage-gated sodium channels in peripheral nerves, while bacitracin zinc inhibits bacterial cell wall synthesis, neomycin sulfate inhibits bacterial protein synthesis by binding the 30S ribosomal subunit, and polymyxin b disrupts the bacterial cell membrane, particularly in susceptible Gram-negative organisms. The product is marketed in ointment and cream presentations under brand names such as Neosporin Plus and related store-brand equivalents; the provided context also links the combination name to painful urethritis, but that urethritis indication more classically corresponds to lidocaine hydrochloride jelly rather than the topical four-component first-aid antibiotic combination.

Brand names
Neosporin PlusTriple Antibiotic Plus LidocaineBiotic-PlusRecelltis
Other names
lidocaine hydrochloride + bacitracin zinc + neomycin sulfate + polymyxin blidocaine hydrochloride + bacitracin zinc + neomycin sulfate + polymyxin b sulfatebacitracin zinc + neomycin sulfate + polymyxin b sulfate + lidocaine hydrochloridetriple antibiotic plus lidocaine
02

Targets

Bacterial RibosomeNaV (Voltage-gated sodium channels)LPS (Lipopolysaccharide)Bacterial cell wall biosynthesis machinery

Beyond the preview

Go deeper on lidocaine hydrochloride + bacitracin zinc + neomycin sulfate + polymyxin b.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine hydrochloride + bacitracin zinc + neomycin sulfate + polymyxin b.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call